Cellular, Tissue, and Gene Therapies Advisory Committee (CTGTAC) Meeting - Day 2 

The CTGTAC committee will meet in open session on both days to discuss the toxicity risks of adeno-associated virus (AAV) vector-based gene therapy products. The discussion topics include safety issues identified during preclinical and/or clinical evaluation, and oncogenicity risks due to vector genome integration.
Captioning:
www.captionedt...